Li Mengya, Liu Yu, Liu Yajun, Yang Lu, Xu Yan, Wang Weiqiong, Jiang Zhongxing, Liu Yanfang, Wang Shujuan, Wang Chong
Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Department of Orthopaedics, Rhode Island Hospital, Warren Alpert Medical School, Brown University, Providence, RI, United States.
Front Oncol. 2021 Sep 6;11:724435. doi: 10.3389/fonc.2021.724435. eCollection 2021.
The prognosis of acute myeloid leukemia (AML) with a normal karyotype is highly heterogonous, and the current risk stratification is still insufficient to differentiate patients from high-risk to standard-risk. Changes in some genetic profiles may contribute to the poor prognosis of AML. Although the prognostic value of G protein subunit alpha 15 () in AML has been reported based on the GEO (Gene Expression Omnibus) database, the prognostic significance of has not been verified in clinical samples. The biological functions of in AML development remain open to investigation. This study explored the clinical significance, biological effects and molecular mechanism of in AML.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to detect the mRNA expression level of in blasts of bone marrow specimens from 154 newly diagnosed adult AML patients and 26 healthy volunteers. AML cell lines, Kasumi-1 and SKNO-1, were used for lentiviral transfection. Cell Counting Kit-8 (CCK8) and colony formation assays were used to determine cell proliferation. Cell cycle and apoptosis were analyzed by flow cytometry. The relevant signaling pathways were evaluated by Western blot. The Log-Rank test and Kaplan-Meier were used to evaluate survival rate, and the Cox regression model was used to analyze multivariate analysis. Xenograft tumor mouse model was used for experiments.
The expression of in adult AML was significantly higher than that in healthy individuals. Subjects with high expression showed lower overall survival and relapse-free survival in adult AML with normal karyotype. High expression was independently correlated with a worse prognosis in multivariate analysis. Knockdown of inhibited cell proliferation and cell cycle progression, and induced cell apoptosis in AML cells. -knockdown induced down-regulation of p-P38 MAPK and its downstream p-MAPKAPK2 and p-CREB. Rescue assays confirmed that P38 MAPK signaling pathway was involved in the inhibition of proliferation mediated by GNA15 knockdown.
In summary, was highly expressed in adult AML, and high expression was independently correlated with a worse prognosis in adult AML with normal karyotype. Knockdown of inhibited the proliferation of AML regulated by the P38 MAPK signaling pathway. Therefore, may serve as a potential prognostic marker and a therapeutic target for AML in the future.
核型正常的急性髓系白血病(AML)预后高度异质性,目前的风险分层仍不足以区分高危和标危患者。一些基因谱的变化可能导致AML预后不良。尽管基于基因表达综合数据库(GEO)报道了G蛋白亚基α15(GNA15)在AML中的预后价值,但GNA15在临床样本中的预后意义尚未得到验证。GNA15在AML发生发展中的生物学功能仍有待研究。本研究探讨了GNA15在AML中的临床意义、生物学效应及分子机制。
采用逆转录定量聚合酶链反应(RT-qPCR)检测154例新诊断的成年AML患者骨髓标本原始细胞及26例健康志愿者中GNA15的mRNA表达水平。使用AML细胞系Kasumi-1和SKNO-1进行慢病毒转染。采用细胞计数试剂盒8(CCK8)和集落形成试验检测细胞增殖。通过流式细胞术分析细胞周期和凋亡。通过蛋白质免疫印迹法评估相关信号通路。采用对数秩检验和Kaplan-Meier法评估生存率,采用Cox回归模型进行多因素分析。采用异种移植肿瘤小鼠模型进行实验。
成年AML中GNA15的表达明显高于健康个体。在核型正常的成年AML中,GNA15高表达患者的总生存期和无复发生存期较低。多因素分析显示,GNA15高表达与较差的预后独立相关。敲低GNA15可抑制AML细胞的增殖和细胞周期进程,并诱导细胞凋亡。敲低GNA15可导致p-P38丝裂原活化蛋白激酶及其下游p-MAPKAPK2和p-CREB的下调。挽救试验证实,P38丝裂原活化蛋白激酶信号通路参与了GNA15敲低介导的增殖抑制。
总之,GNA15在成年AML中高表达,且在核型正常的成年AML中,GNA15高表达与较差的预后独立相关。敲低GNA15可抑制由P38丝裂原活化蛋白激酶信号通路调控的AML增殖。因此,GNA15未来可能作为AML的潜在预后标志物和治疗靶点。